SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-074165
Filing Date
2023-09-06
Accepted
2023-09-06 09:23:09
Documents
12
Period of Report
2023-09-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea184757-8k_relmada.htm   iXBRL 8-K 27467
  Complete submission text file 0001213900-23-074165.txt   200097

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE rlmd-20230905.xsd EX-101.SCH 3012
3 XBRL LABEL FILE rlmd-20230905_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE rlmd-20230905_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT ea184757-8k_relmada_htm.xml XML 3332
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39082 | Film No.: 231238003
SIC: 2834 Pharmaceutical Preparations